Literature DB >> 30450729

Living liver donation improves patient and graft survival in the pediatric population.

Martin I Montenovo1, Kiran Bambha2, Jorge Reyes1,2,3, Andre Dick3, James Perkins1, Patrick Healey3.   

Abstract

BACKGROUND: The utilization of living donor grafts resulted in an increased availability of liver for pediatric recipients, and accordingly, this was associated with a significantly decreased waiting time before liver transplantation as well as reduced pre-transplant mortality. We hypothesized that the use of living donors in pediatric LT may lead to improved graft and patient survival, when compared to LT using deceased donors.
METHODS: Retrospective cohort analysis of pediatric recipients (aged <18 years) registered in the UNOS database who received a primary liver transplant between February 2002 and December 2016. Covariates predictive of survival by multivariable analyses were included in the Cox proportional hazards regression models to determine predictors of patient and graft survival.
RESULTS: A total of 6312 children received a primary LT from a LD (n = 800) or a deceased donor (n = 5517; partial graft n = 1784 and whole graft n = 3733). Vascular and biliary complications were similar. Kaplan-Meier graft and patient survival rates were superior in LD recipients compared with recipients of deceased whole and reduced graft (Figures 1 and 2). In the multivariable analysis, LD were an independent predictor of improved patient and graft survival.
CONCLUSION: The use of LD in children is associated with improved patient and graft survival. The option of LD should be introduced early on in the evaluation of every pediatric patient being evaluated for liver transplant.
© 2018 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2018        PMID: 30450729     DOI: 10.1111/petr.13318

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience.

Authors:  Yafei He; Xinyan Zhao; Jimin Liu; Qian Zhang; Liwei Liu; Wei Qu; Ying Liu; Zhigui Zeng; Haiming Zhang; Jidong Jia; Liying Sun; Lin Wei; Zhijun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

2.  Immunologic benefits of maternal living donor allografts in pediatric liver transplantation: fewer rejection episodes and no evidence of de novo allosensitization.

Authors:  Arianna Barbetta; Glenda Meeberg; Brittany Rocque; Sarah Barhouma; Carly Weaver; Susan Gilmour; Farah Faytrouni; Orlee Guttman; Shannon Zielsdorf; Kambiz Etesami; Yong Kwon; George Yanni; Patricia Campbell; James Shapiro; Juliet Emamaullee
Journal:  Pediatr Transplant       Date:  2021-11-21

3.  Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement.

Authors:  Jean de Ville de Goyet; Toni Illhardt; Christophe Chardot; Peace N Dike; Ulrich Baumann; Katherine Brandt; Barbara E Wildhaber; Mikko Pakarinen; Fabrizio di Francesco; Ekkehard Sturm; Marianna Cornet; Caroline Lemoine; Eva Doreen Pfister; Ana M Calinescu; Maria Hukkinen; Sanjiv Harpavat; Fabio Tuzzolino; Riccardo Superina
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

4.  Living Donor Versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-analysis.

Authors:  Arianna Barbetta; Chanté Butler; Sarah Barhouma; Rachel Hogen; Brittany Rocque; Cameron Goldbeck; Hannah Schilperoort; Glenda Meeberg; James Shapiro; Yong K Kwon; Rohit Kohli; Juliet Emamaullee
Journal:  Transplant Direct       Date:  2021-09-20

5.  Decreased access to pediatric liver transplantation during the COVID-19 pandemic.

Authors:  Sarah Kemme; Dor Yoeli; Shikha S Sundaram; Megan A Adams; Amy G Feldman
Journal:  Pediatr Transplant       Date:  2021-10-11

6.  Over 30 Years of Pediatric Liver Transplantation at the Charité-Universitätsmedizin Berlin.

Authors:  Simon Moosburner; Leke Wiering; Safak Gül-Klein; Paul Ritschl; Tomasz Dziodzio; Nathanael Raschzok; Christian Witzel; Alexander Gratopp; Stephan Henning; Philip Bufler; Moritz Schmelzle; Georg Lurje; Wenzel Schöning; Johann Pratschke; Brigitta Globke; Robert Öllinger
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.